Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HELEN SKOLNICK

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1962409755
CMS profile
1017142
Location
SKILLMAN, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$943.39

52 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $943.39 52

By paying entity

PY2022 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 52 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HELEN SKOLNICK

NPI 1962409755 · CMS profile ID 1017142

Allopathic & Osteopathic Physicians / Allergy & Immunology

SKILLMAN, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 52 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1962409755?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HELEN SKOLNICK, NPI 1962409755, CMS profile ID 1017142. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 52 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1962409755?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). HELEN SKOLNICK, NPI 1962409755, CMS profile ID 1017142. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 52 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1962409755?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
HELEN SKOLNICK, NPI 1962409755, CMS profile ID 1017142, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 52 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1962409755?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

52 matching records · $943.39 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 52 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 52.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $6.1512/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120047 CMS
Novartis Pharmaceuticals Corporation $18.1911/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894386121 CMS
CSL Behring $18.5011/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940852461 CMS
Amgen Inc. $14.6511/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939781033 CMS
AstraZeneca Pharmaceuticals LP $111.9010/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914633399 CMS
GlaxoSmithKline, LLC. $12.9410/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120071 CMS
Aimmune Therapeutics, Inc. $17.3810/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954230071 CMS
Incyte Corporation $17.5810/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943084865 CMS
GlaxoSmithKline, LLC. $12.5909/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120067 CMS
Regeneron Healthcare Solutions, Inc. $14.4409/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927410255 CMS
CSL Behring $19.8809/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940852453 CMS
GlaxoSmithKline, LLC. $9.5008/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120059 CMS
GlaxoSmithKline, LLC. $11.6808/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120045 CMS
GlaxoSmithKline, LLC. $8.8508/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120065 CMS
GlaxoSmithKline, LLC. $8.9208/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120051 CMS
GlaxoSmithKline, LLC. $11.0008/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120083 CMS
GENZYME CORPORATION $14.2608/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938849525 CMS
AstraZeneca Pharmaceuticals LP $11.8107/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914802729 CMS
Aimmune Therapeutics, Inc. $14.0707/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954228799 CMS
GENZYME CORPORATION $11.7507/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938849523 CMS
GlaxoSmithKline, LLC. $11.8807/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120055 CMS
GlaxoSmithKline, LLC. $9.4607/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120049 CMS
kaleo, Inc. $13.9806/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941018363 CMS
GlaxoSmithKline, LLC. $15.0006/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120069 CMS
Regeneron Healthcare Solutions, Inc. $14.1406/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927410247 CMS
GENZYME CORPORATION $12.5906/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938849513 CMS
AstraZeneca Pharmaceuticals LP $14.9906/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914875613 CMS
Incyte Corporation $18.2105/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943084835 CMS
Regeneron Healthcare Solutions, Inc. $12.7505/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927410237 CMS
GlaxoSmithKline, LLC. $10.2105/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120079 CMS
Amgen Inc. $11.1305/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939781029 CMS
Pharming Healthcare, Inc. $15.2205/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 907880955 CMS
CSL Behring $18.0305/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940852439 CMS
Aimmune Therapeutics, Inc. $16.2304/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954232297 CMS
GlaxoSmithKline, LLC. $10.5804/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120077 CMS
GlaxoSmithKline, LLC. $13.2604/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120075 CMS
OptiNose US, Inc. $11.7604/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 928129993 CMS
AstraZeneca Pharmaceuticals LP $13.6004/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915819715 CMS
kaleo, Inc. $13.4903/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941018367 CMS
GlaxoSmithKline, LLC. $11.1303/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120063 CMS
Pharming Healthcare, Inc. $69.7303/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 907880953 CMS
CSL Behring $20.7603/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940852427 CMS
GlaxoSmithKline, LLC. $12.9802/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120053 CMS
GlaxoSmithKline, LLC. $13.0602/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120057 CMS
GlaxoSmithKline, LLC. $15.0002/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120081 CMS
AstraZeneca Pharmaceuticals LP $11.6502/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914877221 CMS
GlaxoSmithKline, LLC. $12.6802/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120061 CMS
AstraZeneca Pharmaceuticals LP $12.6101/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915597415 CMS
AstraZeneca Pharmaceuticals LP $12.7701/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915001739 CMS
GlaxoSmithKline, LLC. $12.8601/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945120073 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $767.43 30
PY2020 $1,074.62 22
PY2021 $892.93 73
PY2022 $943.39 52
PY2023 $665.82 36
PY2024 $803.51 37
PY2025 $1,293.83 61

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Principal investigator $7,410.94 3
PY2021 Principal investigator $40,479.84 32
PY2020 Principal investigator $30,559.62 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

32 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $21.42 12/31/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849615009
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $9,907.81 12/28/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849611555
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $3,809.06 09/21/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849615917
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $401.25 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612273
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $100.31 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612279
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $850.00 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612409
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $401.25 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612415
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $100.31 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612421
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $850.00 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612427
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $401.25 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612433
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $850.00 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612713
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $401.25 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612719
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $100.31 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612725
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $850.00 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612729
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $401.25 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612735
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $100.31 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612741
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $850.00 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849612861
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $100.31 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849613935
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $850.00 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849613941
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $401.25 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849613947
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $100.31 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849613953
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $850.00 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849613959
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $401.25 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849613963
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $100.31 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849613969
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $401.25 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849613975
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $100.31 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849613981
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $850.00 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849613987
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $401.25 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849614065
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $100.31 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849614071
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $850.00 06/22/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849614077
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $12,654.38 06/08/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849614087
Principal investigator 1 AIMMUNE THERAPEUTICS, INC. $1,923.13 03/09/2021 Non-covered Recipient Entity
PRINCETON CENTER FOR CLINICAL RESEARCH
A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY No dispute reported 06/30/2026 849614083